94 related articles for article (PubMed ID: 6329773)
1. Comparison of the effectiveness of different opioid peptides in suppressing heroin withdrawal.
Wen HL; Ho WK; Wen PY
Eur J Pharmacol; 1984 Apr; 100(2):155-62. PubMed ID: 6329773
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive profiles of opioid peptide agonists in a rat tooth pulp stimulation procedure.
Steinfels GF; Cook L
Peptides; 1985; 6 Suppl 2():171-5. PubMed ID: 2867529
[TBL] [Abstract][Full Text] [Related]
3. Possible regulatory role of dynorphin on morphine- and beta-endorphin-induced analgesia.
Tulunay FC; Jen MF; Chang JK; Loh HH; Lee NM
J Pharmacol Exp Ther; 1981 Nov; 219(2):296-8. PubMed ID: 6116798
[TBL] [Abstract][Full Text] [Related]
4. Motility effects of opioid peptides in dog intestine.
Burks TF; Hirning LD; Galligan JJ; Davis TP
Life Sci; 1982 Nov 15-22; 31(20-21):2237-40. PubMed ID: 6298519
[TBL] [Abstract][Full Text] [Related]
5. Possible regulatory role of dynorphin-(1-13) on narcotic-induced changes in naloxone efficacy.
Tulunay FC; Jen MF; Chang JK; Loh HH; Lee NM
Eur J Pharmacol; 1981 Dec; 76(2-3):235-9. PubMed ID: 6277644
[TBL] [Abstract][Full Text] [Related]
6. Suppression of withdrawal symptoms by dynorphin in heroin addicts.
Wen HL; Ho WK
Eur J Pharmacol; 1982 Aug; 82(3-4):183-6. PubMed ID: 6127224
[TBL] [Abstract][Full Text] [Related]
7. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
[TBL] [Abstract][Full Text] [Related]
8. Opioid peptides increase calcium uptake by synaptosomes from brain regions.
Barr E; Leslie SW
Brain Res; 1985 Mar; 329(1-2):280-4. PubMed ID: 2858254
[TBL] [Abstract][Full Text] [Related]
9. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
[TBL] [Abstract][Full Text] [Related]
10. Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration.
Werz MA; Macdonald RL
J Pharmacol Exp Ther; 1985 Jul; 234(1):49-56. PubMed ID: 2409273
[TBL] [Abstract][Full Text] [Related]
11. Decreased dihydromorphine and D-ALA2-D-LEU5-enkephalin binding in vitro after dynorphin pretreatment in mice in vivo.
Jen MF; Garzón J; Lee NM
Life Sci; 1982 Oct 18-25; 31(16-17):1813-6. PubMed ID: 6130446
[No Abstract] [Full Text] [Related]
12. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
Kirby GC; McQueen DS
Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
[TBL] [Abstract][Full Text] [Related]
13. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
Tseng LF; Cheng SS; Fujimoto JM
J Pharmacol Exp Ther; 1983 Jan; 224(1):51-4. PubMed ID: 6294283
[TBL] [Abstract][Full Text] [Related]
15. Actions of D-Ala2-D-Leu5-enkephalin and dynorphin A (1-17) on neocortical neurons in vitro.
Sutor B; Zieglgänsberger W
Neuropeptides; 1984 Dec; 5(1-3):241-4. PubMed ID: 6152323
[TBL] [Abstract][Full Text] [Related]
16. Ontogenetic development of the pro-enkephalin B (= pro-dynorphin) opioid peptide system in the rat pituitary.
Seizinger BR; Liebisch DC; Grimm C; Herz A
Neuroendocrinology; 1984 Nov; 39(5):414-22. PubMed ID: 6151128
[TBL] [Abstract][Full Text] [Related]
17. Mu-, delta-, kappa- and epsilon-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides.
Iyengar S; Kim HS; Wood PL
Brain Res; 1987 Dec; 435(1-2):220-6. PubMed ID: 2892574
[TBL] [Abstract][Full Text] [Related]
18. The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats.
Nylander I; Vlaskovska M; Terenius L
Psychopharmacology (Berl); 1995 Apr; 118(4):391-400. PubMed ID: 7568625
[TBL] [Abstract][Full Text] [Related]
19. Dynorphin-(1-13): the effect of in vivo treatment on opiate bindings in vitro.
Jen MF; Garzon J; Loh HH; Lee NM
Eur J Pharmacol; 1983 Jul; 91(1):95-9. PubMed ID: 6311575
[TBL] [Abstract][Full Text] [Related]
20. Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions.
Katoh A; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1990 May; 253(2):600-7. PubMed ID: 1971017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
